MedicarePartD.guide

A non-government resource built from CMS public data

2026 HealthSpring Assurance Rx (PDP) formulary (drug list)

Contract S5617, plan 148 · Oregon · 3,188 drugs on file · formulary ID 00026089. Each drug links to its cost in every CMS PDP Region 30 plan.

Hide drugs on tiers

51 drugs starting with X.

Drug nameTier30-day preferred pharmacy90-day mail orderUsage management
XALKORI 150 mg Capsule, Coated PelletsCrizotinib5Specialty Tier25%N/A
  • PA
  • QL 18 per 30 days
XALKORI 20 mg Capsule, Coated PelletsCrizotinib5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
XALKORI 200 mg CapsuleCrizotinib5Specialty Tier25%N/A
  • PA
  • QL 6 per 30 days
XALKORI 250 mg CapsuleCrizotinib5Specialty Tier25%N/A
  • PA
  • QL 6 per 30 days
XALKORI 50 mg Capsule, Coated PelletsCrizotinib5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
XARAH FE KitNorethindrone Acetate And Ethinyl Estradiol And Ferrous Fumarate Tablets4Non-Preferred Drug30%30%None
XARELTO 10 mg Tablet, Film CoatedRivaroxaban3Preferred Brand24%24%None
XARELTO 15 mg Tablet, Film CoatedRivaroxaban3Preferred Brand24%24%None
XARELTO 2.5 mg Tablet, Film CoatedRivaroxaban3Preferred Brand24%24%None
XARELTO 20 mg Tablet, Film CoatedRivaroxaban3Preferred Brand24%24%None
XARELTO KitRivaroxaban3Preferred Brand24%24%None
XATMEP 2.5 mg/mL SolutionMethotrexate4Non-Preferred Drug30%30%None
XCOPRI 100 mg Tablet, Film CoatedCenobamate5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
XCOPRI 150 mg Tablet, Film CoatedCenobamate5Specialty Tier25%N/A
  • PA
  • QL 6 per 30 days
XCOPRI 200 mg Tablet, Film CoatedCenobamate5Specialty Tier25%N/A
  • PA
  • QL 6 per 30 days
XCOPRI 25 mg Tablet, Film CoatedCenobamate5Specialty Tier25%N/A
  • PA
  • QL 48 per 30 days
XCOPRI 50 mg Tablet, Film CoatedCenobamate5Specialty Tier25%N/A
  • PA
  • QL 24 per 30 days
XCOPRI MAINTENANCE PACK KitCenobamate5Specialty Tier25%N/A
  • PA
  • QL 56 per 28 days
XCOPRI MAINTENANCE PACK KitCenobamate5Specialty Tier25%N/A
  • PA
  • QL 56 per 28 days
XCOPRI TITRATION PACK KitCenobamate4Non-Preferred Drug30%30%
  • PA
  • QL 56 per 365 days
XCOPRI TITRATION PACK KitCenobamate5Specialty Tier25%N/A
  • PA
  • QL 56 per 365 days
XCOPRI TITRATION PACK KitCenobamate5Specialty Tier25%N/A
  • PA
  • QL 56 per 365 days
XDEMVY 2.5 mg/mL Solution/ DropsLotilaner Ophthalmic Solution4Non-Preferred Drug30%30%
  • PA
  • QL 1 per 42 days
XERMELO 250 mg TabletTelotristat Ethyl5Specialty Tier25%N/A
  • PA
  • QL 84 per 28 days
XGEVA 120 mg/1.7mL InjectionDenosumab5Specialty Tier25%N/A
  • PA
  • QL 1.7 per 28 days
XIFAXAN 200 mg TabletRifaximin4Non-Preferred Drug30%30%
  • PA
  • QL 9 per 30 days
XIFAXAN 550 mg TabletRifaximin5Specialty Tier25%N/A
  • PA
  • QL 9 per 30 days
XIGDUO XR 10/1000 mg Tablet, Film Coated, Extended ReleaseDapagliflozin And Metformin Hydrochloride3Preferred Brand24%24%
  • QL 3 per 30 days
XIGDUO XR 10/500 mg Tablet, Film Coated, Extended ReleaseDapagliflozin And Metformin Hydrochloride3Preferred Brand24%24%
  • QL 3 per 30 days
XIGDUO XR 2.5/1000 mg Tablet, Film Coated, Extended ReleaseDapagliflozin And Metformin Hydrochloride3Preferred Brand24%24%
  • QL 6 per 30 days
XIGDUO XR 5/1000 mg Tablet, Film Coated, Extended ReleaseDapagliflozin And Metformin Hydrochloride3Preferred Brand24%24%
  • QL 6 per 30 days
XIGDUO XR 5/500 mg Tablet, Film Coated, Extended ReleaseDapagliflozin And Metformin Hydrochloride3Preferred Brand24%24%
  • QL 6 per 30 days
XOFLUZA 40 mg Tablet, Film CoatedBaloxavir Marboxil4Non-Preferred Drug30%30%None
XOFLUZA 80 mg Tablet, Film CoatedBaloxavir Marboxil4Non-Preferred Drug30%30%None
XOLAIR 150 mg/1.2mL Injection, SolutionOmalizumab5Specialty Tier25%N/A
  • PA
  • QL 8 per 28 days
XOLAIR 300 mg/2mL Injection, SolutionOmalizumab5Specialty Tier25%N/A
  • PA
  • QL 8 per 28 days
XOLAIR 300 mg/2mL Injection, SolutionOmalizumab5Specialty Tier25%N/A
  • PA
  • QL 8 per 28 days
XOLAIR PFS 150 mg/mL Injection, SolutionOmalizumab5Specialty Tier25%N/A
  • PA
  • QL 8 per 28 days
XOLAIR PFS 75 mg/.5mL Injection, SolutionOmalizumab5Specialty Tier25%N/A
  • PA
  • QL 1 per 28 days
XOSPATA 40 mg TabletGilteritinib5Specialty Tier25%N/A
  • PA
XPOVIO 10 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 20 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 20 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 40 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 40 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 50 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 60 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XPOVIO 80 mg Tablet, Film CoatedSelinexor5Specialty Tier25%N/A
  • PA
XTANDI 40 mg CapsuleEnzalutamide5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
XTANDI 40 mg TabletEnzalutamide5Specialty Tier25%N/A
  • PA
  • QL 12 per 30 days
XTANDI 80 mg TabletEnzalutamide5Specialty Tier25%N/A
  • PA
  • QL 6 per 30 days

PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.